Hui Guo

Dr. Hui Guo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
RGRuitong Gao
Ruitong Gao
HGHui Guo
Hui Guo
YLYandi Liu
Yandi Liu
YPYue Pang
Yue Pang
XZXin Zhang
Xin Zhang
FLFeng Li
Feng Li

13 July 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
LLLei Li
Lei Li
ZWZe Wang
Ze Wang
HGHui Guo
Hui Guo
QLQuan Lin
Quan Lin
Thyroid cancer, the most common malignancy in the head and neck region, has shown an increasing incidence trend. With the continuous advancement of nanotechnology, nanomaterials hold great promise in providing diagnosis and treatment of thyroid cancer.

18 July 2023 in Frontiers in Genetics
Verified
Journal Article
Open access
ZZZijun Zheng
Zijun Zheng
HLHuiping Li
Huiping Li
RYRunjiao Yang
Runjiao Yang
HGHui Guo
Hui Guo
Lung adenocarcinoma, which is the second most prevalent cancer in the world, has a poor prognosis and a low 5-year survival rate. The MS4A protein family is crucial to disease development and progression, particularly for cancers, allergies, metabolic disorders, autoimmune diseases, infections, and neurodegenerative disorders. However, its involvement in lung adenocarcinoma remains unclear. In this study, we found that 11 MS4A family genes were upregulated or downregulated in lung adenocarcinoma. Furthermore, we described the genetic variation landscape of the MS4A family in lung adenocarcinoma. Notably, through functional enrichment analysis, we discovered that the MS4A family is involved in the immune response regulatory signaling pathway and the immune response regulatory cell surface receptor signaling pathway. According to the Kaplan–Meier curve, patients with lung adenocarcinoma having poor expression of MS4A2, MS4A7, MS4A14, and MS4A15 had a low overall survival rate. These four prognostic genes are substantially associated with immune-infiltrating cells, and a prognosis model incorporating them may more accurately predict the overall survival rate of patients with lung adenocarcinoma than current models. The findings of this study may offer creative suggestions and recommendations for the identification and management of lung adenocarcinoma.

12 January 2026 in Biomaterials
Verified
Journal Article
Closed access
LLLei Li
Lei Li
ALAnnan Liu
Annan Liu
ZWZe Wang
Ze Wang
HLHao Liang
Hao Liang
AWAndrew K. Whittake
Andrew K. Whittake
QLQuan Lin
Quan Lin

5 January 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
YYYing Yang
Ying Yang
HSHua Shu
Hua Shu
JHJingxin Hu
Jingxin Hu
LLLei Li
Lei Li
JWJianyu Wang
Jianyu Wang
MLMing Liu
Ming Liu
Preproinsulin (PPI) translocation across the membrane of the endoplasmic reticulum (ER) is the first and critical step of insulin biosynthesis. Inefficient PPI translocation caused by signal peptide (SP) mutations can lead to β-cell failure and diabetes. However, the effect of proinsulin domain on the efficiency of PPI translocation remains unknown. With whole exome sequencing, we identified a novel INS nonsense mutation resulting in an early termination at the 46th residue of PPI (PPI-R46X) in two unrelated patients with early-onset diabetes. We examined biological behaviors of the mutant and compared them to that of an established neonatal diabetes causing mutant PPI-C96Y. Although both mutants were retained in the cells, unlike C96Y, R46X did not induce ER stress or form abnormal disulfide-linked proinsulin complexes. More importantly, R46X did not interact with co-expressed wild-type (WT) proinsulin in the ER, and did not impair proinsulin-WT folding, trafficking, and insulin production. Metabolic labeling experiments established that, despite with an intact SP, R46X failed to be efficiently translocated into the ER, suggesting that proinsulin domain downstream of SP plays an important unrecognized role in PPI translocation across the ER membrane. The study not only expends the list of INS mutations associated with diabetes, but also provides genetic and biological evidence underlying the regulation mechanism of PPI translocation.

16 February 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
YWYichen Wang
Yichen Wang
LJLin Jia
Lin Jia
CWCong Wang
Cong Wang
ZDZhonghua Du
Zhonghua Du
SZShilin Zhang
Shilin Zhang
Jifan HuJifan Hu
Jifan Hu
The molecular circuitry that causes stem cells to exit from pluripotency remains largely uncharacterized. Using chromatin RNA in situ reverse transcription sequencing, we identified Peln1 as a novel chromatin RNA component in the promoter complex of Oct4, a stem cell master transcription factor gene. Peln1 was negatively associated with pluripotent status during somatic reprogramming. Peln1 overexpression caused E14 cells to exit from pluripotency, while Peln1 downregulation induced robust reprogramming. Mechanistically, we discovered that Peln1 interacted with the Oct4 promoter and recruited the DNA methyltransferase DNMT3A. By de novo altering the epigenotype in the Oct4 promoter, Peln1 dismantled the intrachromosomal loop that is required for the maintenance of pluripotency. Using RNA reverse transcription-associated trap sequencing, we showed that Peln1 targets multiple pathway genes that are associated with stem cell self-renewal. These findings demonstrate that Peln1 can act as a new epigenetic player and use a trans mechanism to induce an exit from the pluripotent state in stem cells.